Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by Xiawen13on Feb 21, 2016 10:08am
259 Views
Post# 24579248

The real question is...

The real question is...Please tell me if I get this right:

MCNA phase three trial has been completed YEARs ago, the results were deemed inconclusive so ENDO litteraly returned us the rights on the product, Dr Alvarez article on MCNA phase three has been published  everywhere on the internet the last couple of month but  where never published before that, and finally no registration process has ever been filed in any country so far exept with FDA altought MCNA has been around for years!!

I STILL DONT UNDERSTAND WHAT HAPPENED BETWEEN THE END OF THE TRIALS YEARS AGO AND THE SUDDEN REBRANDING OF BIONICHE AND SUSEQUENT APPLICATION FOR BLA


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse